IANNONE, LUIGI FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 3.254
NA - Nord America 3.188
EU - Europa 2.066
SA - Sud America 378
AF - Africa 74
OC - Oceania 51
Totale 9.011
Nazione #
US - Stati Uniti d'America 3.090
CN - Cina 1.125
RU - Federazione Russa 976
SG - Singapore 894
IT - Italia 588
HK - Hong Kong 347
KR - Corea 343
BR - Brasile 292
VN - Vietnam 198
FR - Francia 109
IN - India 93
IE - Irlanda 69
FI - Finlandia 65
BD - Bangladesh 61
DE - Germania 61
MX - Messico 53
GB - Regno Unito 52
AU - Australia 51
ID - Indonesia 49
SE - Svezia 40
CA - Canada 35
AR - Argentina 34
NL - Olanda 27
JP - Giappone 24
CH - Svizzera 22
NG - Nigeria 18
EC - Ecuador 16
BJ - Benin 14
IQ - Iraq 14
JO - Giordania 14
ZA - Sudafrica 14
PK - Pakistan 13
CO - Colombia 10
IR - Iran 10
CL - Cile 9
MA - Marocco 9
UA - Ucraina 9
MY - Malesia 8
PH - Filippine 8
PL - Polonia 8
EG - Egitto 7
TR - Turchia 7
TW - Taiwan 7
ES - Italia 6
PE - Perù 6
PT - Portogallo 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AT - Austria 5
LT - Lituania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CI - Costa d'Avorio 4
TH - Thailandia 4
TN - Tunisia 4
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GR - Grecia 2
GT - Guatemala 2
KZ - Kazakistan 2
MK - Macedonia 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
TT - Trinidad e Tobago 1
Totale 9.011
Città #
Santa Clara 1.029
Singapore 692
Ashburn 509
Hefei 473
Seoul 340
Hong Kong 307
San Jose 181
Beijing 113
Los Angeles 89
Council Bluffs 81
Milan 80
Ho Chi Minh City 69
Moscow 68
Florence 66
Dublin 64
Lauterbourg 56
Kent 55
The Dalles 55
Rome 51
Buffalo 50
Melbourne 43
Chicago 42
Dallas 42
Helsinki 42
Hanoi 39
Bengaluru 37
Jakarta 34
New York 34
Munich 26
São Paulo 26
Mumbai 23
Paris 23
Shanghai 22
Altamura 20
Lawrence 20
Abuja 18
West Jordan 18
Lappeenranta 17
London 17
Chandler 16
Coppell 15
Tokyo 15
Boardman 14
Cotonou 14
Fontebuona 14
Bologna 13
Gustavo Adolfo Madero 13
Haiphong 13
Turin 12
Washington 12
Boston 11
Orem 11
Salt Lake City 11
Seattle 11
Wilmington 11
Bern 10
Houston 10
Phoenix 10
Princeton 10
Rio de Janeiro 10
Atlanta 9
Brescia 9
Frankfurt am Main 9
Johannesburg 9
Miano 9
Philadelphia 9
Brooklyn 8
Lausanne 8
Naples 8
Benito Juarez 7
Catania 7
Denver 7
Gioia Tauro 7
Guayaquil 7
Modena 7
Nagoya 7
Porto Alegre 7
Sydney 7
Toronto 7
Bari 6
Buenos Aires 6
Elk Grove Village 6
Fairfield 6
Guangzhou 6
Montreal 6
Padua 6
Quito 6
Turku 6
Warsaw 6
Yubileyny 6
Baghdad 5
Changsha 5
Chennai 5
Curitiba 5
Kyiv 5
Lisbon 5
Livorno 5
Medford 5
Messina 5
Mexico City 5
Totale 5.491
Nome #
Gut microbiota manipulation as an epilepsy treatment 375
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability 294
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score 267
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series 247
Current status and future perspectives in HER2 positive advanced gastric cancer 201
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 187
Clinically relevant drug interactions between statins and antidepressants 179
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 173
Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients 170
A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study 167
Microbiota-gut brain axis involvement in neuropsychiatric disorders 167
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 166
The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models 165
The trpa1 channel amplifies the oxidative stress signal in melanoma 164
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine 162
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea 162
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network 160
Non-neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats 158
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis 157
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) 157
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine 157
Emerging Pharmacological Treatments for Migraine in the Pediatric Population 156
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 154
Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma 148
The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers 144
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome 138
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 138
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 137
Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs 135
The role of TRP ion channels in migraine and headache 135
Can we 'seize' the gut microbiota to treat epilepsy? 134
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 132
Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era 131
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 130
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 130
Status epilepticus in pregnancy: a literature review and a protocol proposal 127
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? 127
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine 125
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report 125
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 124
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 124
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany 122
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 122
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 121
Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy 120
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 119
The gut microbiome and efficacy of cancer immunotherapy 119
Renal denervation for resistant hypertension 117
Migraine Treatment: Towards New Pharmacological Targets 116
Ixekizumab May Improve Renal Function in Psoriasis 116
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY) 115
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study 110
Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy 110
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine 110
Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief 106
Gut microbiota and psychogenic non-epileptic seizures: i can feel it in the belly 106
Management of status epilepticus in patients with liver or kidney disease: a narrative review 105
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 98
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 94
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 90
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy 87
The potential role of interventions impacting on gut-microbiota in epilepsy 76
Immunotherapy-related biomarkers: Confirmations and uncertainties 68
Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective study 21
Totale 9.097
Categoria #
all - tutte 27.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202274 0 0 0 0 0 0 0 18 15 10 15 16
2022/2023314 13 51 15 9 1 37 35 12 16 29 68 28
2023/2024587 13 31 57 34 39 61 33 136 59 61 50 13
2024/20253.288 92 309 184 418 804 463 124 152 109 191 161 281
2025/20264.634 504 711 795 581 377 144 444 221 204 233 158 262
2026/2027200 200 0 0 0 0 0 0 0 0 0 0 0
Totale 9.097